Summary
We present a case report on a 35-year-old patient in whom a malignant sympathetic paraganglioma of the organ of Zuckerkandl was the cause of severe hypertension with excessive perspiration at night. Since curative surgery was not possible medical treatment was initiated. Interferon alfa 2b (Intron A, Essex Pharma) and the somatostatin-analogue SMS 201–995 (Sandostatin, Sandoz) had no effect on catecholamine production and progression of the tumor. Treatment with alpha-methyl-para-tyrosin (MPT, [Metyrosin], Demser, MSD) turned out to be an effective and well tolerable therapy in this patient with peritoneal carcinosis. Clinical and hormonal progression of the paraganglioma resumed only after two years of therapy, which constitutes the longest documented period of time of successful MPT treatment. The superior efficacy of MPT in our patient should encourage postoperative medical treatment with MPT in malignant pheochromocytoma or malignant paraganglioma, particularly when the tumor turns out to be resistent to alpha blocking drugs.
Similar content being viewed by others
Abbreviations
- BKS:
-
Blutkörperchensenkungsgeschwindigkeit
- DOPA:
-
3,4-Dihydroxyphenylalanin gamma
- GT:
-
Gamma-Glutamyl-Transferase
- GOT:
-
Glutamat-Oxalazetat-Transaminase
- GPT:
-
Glutamat-Pyruvat-Transaminase
- Gy:
-
Gray-Einheit
- HPLC:
-
Hochdruck-Flüssigkeits-Chromatographie
- IU:
-
International Units
- J-MIBG:
-
Jodmetajodobenzylguanidin
- MPT:
-
alpha-methyl-para-tyrosin (Metyrosin)
- PTH:
-
Parathormon
- SMS:
-
Somatostatin
- TT3:
-
gesamtes Trijodthyronin
- TT4:
-
gesamtes Tetrajodthyronin (Thyroxin)
- TBG:
-
Thyroxin-bindendes Globulin
- TSH:
-
Thyreoidea-Stimulierendes-Hormon
Literatur
Averbuch ASD, Steakley CS, Young RC, Gelmann EP, Goldstein DS, Stull R, Keiser HR (1988) Malignant pheochromocytoma: effective treatment with a combination of cyclophosphamide, vincristine and dacarbazine. Ann Intern Med 109:267–273
Brogden RN, Heel RC, Speight TM, Avery GS (1981) Alpha-methyl-para-tyrosine: A review of its pharmacology and clinical use. Drugs 21:81–89
Chevinsky AH, Minton JP, Falko JM (1990) Metastatic pheochromocytoma associated with multiple endocrine neoplasia syndrome type II. Arch Surg 125:935–938
Eriksson B, öberg K, Alm G, Karlsson A, Lundquist G, Magnusson A, Wide L, Wilander E (1987) Treatment of malignant endocrine pancreatic tumors with human leukocyte interferon. Cancer Treat Rep 71 (1):31–37
Fischer M (1987) Stellenwert des MIBG in der Diagnostik und Therapie chromaffiner Tumoren. In: Engelhardt D, Mann K (Hrsg) Endokrin-aktive maligne Tumoren, 1. Aufl. Springer, Berlin Heidelberg New York, S 124–131
Hauptmann JB, Modlinger RS, Ertel NH (1983) Pheochromocytoma resistent to alpha-adrenergic blockade. Arch Intern Med 143:2321–2323
Imperato-McGinley J, Gautier T, Ehlers K, Zullo MA, Goldstein DS, Vaughan ED (1987) Reversibility of catecholamine-induced dilated cardiomyopathy in a child with a pheochromocytoma. N Engl J Med 13:793–797
Kuchel O, Buu NT, Edwards DJ (1990) Alternative catecholamine pathways after tyrosine hydroxylase inhibition in malignant pheochromocytoma. J Lab Clin Med 115:449–453
Landsberg L, Young JB (1985) Catecholamines and the adrenal medulla. In: Wilson JD, Foster DW (eds) Williams Textbook of Endocrinology, 7th edn. Saunders, Philadelphia, pp 891–965
Löhrs U (1987) Morphologische und immunhistochemische Befunde bei malignen endokrinen Tumoren. In: Engelhardt D, Mann K (Hrsg) Endokrin-aktive maligne Tumoren, 1. Aufl. Springer, Berlin Heidelberg New York, S 1–10
Manger WM, Gifford RW (1977) Pheochromocytoma. Springer, Berlin Heidelberg New York
Moertel CG, Rubin J, Kvols LK (1989) Therapy of metastatic carcinoid tumor and the malignant carcinoid syndrome with recombinant leukocyte A interferon. J Clin Oncol 7:865–868
Saller B, Jacob K, Markl A, Zwiebel FM, Engelhardt D, Mann K (1989) Rezidivierende Hochdruckkrisen und Dyspnoe nach einseitiger Adrenalektomie wegen Phäochromozytom bei einer 44jährigen Patientin. Der Internist 31:78–81
Schmoll HJ, Peters HD, Fink U (1987) Phäochromozytom. Kompendium internistische Onkologie. Springer, Berlin Heidelberg New York, S 865–871
Schöber C, Schuppert F, Schmoll E, Stahl M, Poliwoda H, Wilke H, Schmoll HJ (1989) Interferon alpha 2b in patients with advanced neuroendocrine gut tumors. Molecular Biotherapy 1 [Suppl] abstract 100
Schuppert F, Schöber C, Schmoll E, Stahl M, Poliwoda H, Wilke H, Schmoll HJ, von zur Mühlen A (1990) Interferon alpha 2b in patients with neuroendocrine gut tumors (carcinoids) and endocrine pancreatic tumors (EPT). Acta Endocrinologica 122 (1):45, abstract 89
Schürmeyer TH, Dralle H, Schuppert F, von zur Mühlen A (1988) Präoperative Diagnostik bei Verdacht auf Phäochromozytom-retrospektive Beurteilung diagnostischer Kriterien. Acta Med Austriaca 4:106
Serri O, Comtois R, Bettez P, Dubuc P, Buu NT, Kuchel O (1984) Reduction in the size of a pheochromocytoma pulmonary metastasis by metyrosine therapy. N Engl J Med 310:1264–1265
Sheps SG, Jiang N-S, Klee GG, Van Heerden JA (1990) Recent developments in the diagnosis and treatment of pheochromocytoma. Mayo Clin Proc 65:88–95
Sisson J, Frager MS, Valk TW, Gross MD, Swanson DP, Wieland DM, Tobes MC, Beierwalter WH, Thompson NW (1981) Scintigraphic localization of pheochromocytoma. N Engl J Med 305:12–17
Tippett PA, McEwan AJ, Ackery DM (1986) A re-evaluation of dopamine excretion in pheochromocytoma. Clin Endocrinol 25:401–410
Trautmann ME, Neuhaus C, Willemer S, Hügens-Penzel M, Koop H, Schwerk WB, Arnold R (1990) Hormone secretion and growth of endocrine gastrointestinal tumors during treatment with a somatostatin-analogue. Acta Endocrinologica 122 (1):23, abstract 45
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schuppert, F., Scheumann, G.F.W., Schöber, C. et al. Therapie eines malignen sympathischen Paraganglioms des Zuckerkandl'schen Organs — ein Fallbericht. Klin Wochenschr 69, 937–942 (1991). https://doi.org/10.1007/BF01798547
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01798547